Smith & Nephew PLC's (LSE:SN) new strategic plan and 2028 outlook look ambitious, City analysts said, but have been received with some heavy dashes of scepticism. UBS, which kept its rating on the s
Smith & Nephew PLC (LSE:SN) has launched a new corporate strategy designed to give stronger returns for shareholders, alongside issuing medium-term financial targets through to 2028, alongside update
British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million and unveiled new medium-term targets ahead of its Capital Markets Day Event on Monday.
Trinity Biotech (NASDAQ: TRIB - Get Free Report) and Smith and Nephew SNATS (NYSE: SNN - Get Free Report) are both medical companies, but which is the better investment? We will compare the two busine
Creative Planning cut its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 13.7% in the second quarter, according to the company in its most recent filing with the Securities and Exch
For a business built on orthopaedics and wound care, Smith & Nephew PLC (LSE:SN) has given investors a fair bit of whiplash. Its third-quarter update sent the shares down about 10% after organic reven
Smith & Nephew plc ( SNN ) Q3 2025 Sales Call November 6, 2025 3:30 AM EST Company Participants Deepak Nath - CEO & Director John Rogers - CFO & Executive Director Conference Call Participants Jack Re

Smith & Nephew plunges as weaker US knees

07:01am, Thursday, 06'th Nov 2025
Smith & Nephew PLC (LSE:SN) shares were the worst faller on the FTSE 100 on Thursday morning, down 12% after reporting lower revenues than expected Third-quarter revenue growth came in at 5.0%, below
Envestnet Asset Management Inc. lowered its position in Smith and Nephew SNATS, Inc. (NYSE: SNN) by 12.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the
Smith & Nephew plc maintains a 'Hold' rating due to valuation concerns and limited near-term upside despite recent operational improvements. Sequential growth across all business units and a 100 basis
Ethic Inc. trimmed its stake in Smith and Nephew SNATS, Inc. (NYSE: SNN) by 17.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound thera
Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts or
SmithNephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the bette
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE